1 罗助荣, 郑冰.高血压患者压力反射敏感性与部分内分泌激素的相关性研究.临床心血管杂志, 1998;14(6):347
2 Harrington F, Murray A, Ford GA.Relationship of baro reflex sensitivity and blood pressure in an older population.J Hy pertens, 2000;18(11):1629
3 Reyesdel Paso GA.A biofeedback system of baroreceptor cardiac reflex sensitivity.Appl Psychophy siol Biofeedback, 1999;24(1):67
4 Mark AL.Reg ulation of sympathetic nervous activity in mild human hy pertension.J Hy pertens, 1990;8(suppl 7): S67
5 Mancia G, Grassi G, Parati G, et al.The sympathe tic nervous system in human hy pertension. Acta Physiol Scand, 1997;640:117
6 Clement DL.Blood pressure variability.London:Academic Press Inc.Ltd, 1981:607
7 Mancia G, Omboni S, Parati G.The impo rtance of blood pressure variability in hy pertension.Blood Press Monit, 2000;5 (suppl 1):S9
8 Hilz M J, Stemper B, Neundorfer B.Physiology and methods for studying the barorecepto r reflex.Fortschr Neurol Psy chiatr, 2000;68(1):37
9 Galust'ian GE, Gav rikov KE.The variability characteristics of the ar terial pressure in man and animals.Usp Fiziol Nauk, 1999;30(4):67
10 Rig oyen MC, Krieger EM.Baroreflex control of sympathetic activity in experimental hy pertension.Braz J Med Biol Res, 1998;31(9):1213
11 Head GA, Malpas SC.Baroreflex mechanisms in hypertension. Fund Clin Pharmacol, 1997;Ⅱ (suppl):S65
12 Chapleau MW, Abboud FM.Mo dulation of barorecepto r activity by ionic and paracine mechanism:an o verview. Braz J Med Biol Res, 1994;27:1001
13 Raimondi G, Iellamo F, Leg ramante JM.Spo ntaneous baroreflex control of heart rate during chro nic tandro pril therapy.Cardiologia, 1998;43(4):395
14 Vaile JC, Jordan PJ, Stallard TJ, et al.The effects of acute and chronic dihydropy ridine.Hum Hy pertens, 2000; 14(3):189
15 Pereira de Souza Ne to E, Frutoso J, Somody L.Effect of acute atenolo l on short-term blood pressure v ariability and baroreflex.Fundam Clin Pharmacol, 2000;14(4):341
16 Floras JS, Jones JV, Hassan MO.Effects of acute and chronic beta-adrenocepto rblockade on baro reflex sensitivity in human.J Auton Nerv Syst, 1988;25(2～3):87
17 Chen X, Hassan MO, Jones JV.Baroreflex sensitivity and the blood pressure response to beta-blo ckade.J Hum Hypertens, 1999;13(3):185
18 夏林英, 钮伟真, 沈靖, 等.一氧化氮及去内皮对颈动脉窦压力感受器活动的影响.生理学报, 1998;50(6):611
19 Wrig ht, James M, Lee CH, et al.Systematic review of antihyper tensive therapies:Does the evidence assist in choosing a first-line drug? CMAJ, 1999;161(1):25
20 Convertino VA, Baumg ar tner N.Effects of hypovolemia on aor tic baroreflex control of heart rate in humans.Aviat Space Enviro n Med, 1997;68(9 Pt 1):838
21 Zito M, Cervone C, D'Aviero M, et al.The effects of sodium depletion on ambulato ry blood pressure and heart rate monitoring in the elderly.J Hy pertens, 1992(suppl); 10(2):S59
22 Bissoli NS, Cicilini MA, Vasquez EC, et al.The diuretic chlor thalido ne normalizes baro receptor and Bezold-Jarisch reflex es in DOCA-salt hypertensive rats.Pharmacol Res, 2000;41(4):483
23 Ylitalo A, Airaksinen KE, Sellin L, et al.Effects of combination antihy pertensive therapy on baroreflex sensitivity and heart rate variability in systemic hy pertension.Am J Cardiol, 1999;83(6):885
24 Kageyama M, Nishimura K, Takada T, et al.SD 3211, a novel benzo thiazine calcium antagonist, alone and in combination with a beta-adrenoceptor antagonist, produces antihypertensive effect without affecting heart ra te and atrioventricular conduction in conscious renal hyper tensive dog. J Cardiovasc Pharmacol, 1991;17:102
25 张雅兰, 傅绍萱, 李蕴山.间尼索地平对麻醉大鼠动脉压力感受性反射敏感性的影响.中国药理学报, 1994;15 (5):466

[1]	CHEN Xi, LI Yongjun. Effects of Chinese patent medicine for activating blood circulation on cardiac repair after myocardial infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 680-688.
[2]	XU Jianfei, LIN Li. Research progress in pharmacological and non-pharmacological treatments of hypertension [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 433-441.
[3]	YUAN Zhen, CHEN Bilian. Review of bleeding events in clinical studies of clopidogrel [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 341-349.
[4]	XING Kai, GONG Jinyu, LUO Jianquan. Advances on pharmacogenomics of diuretics-related adverse reactions [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 204-212.
[5]	DANG Xiangji, ZHOU Lin, WANG Yixuan, ZENG Lu. Individualized antithrombotic therapy on one patient with chronic renal insufficiency [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 477-480.
[6]	PU Chun, TAO Qingsong, ZHU Xiang, QIN Mingming, WU Qiwen, FENG Gang. Value of three cardiac markers in the early diagnosis of acute myocardial infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 82-86.
[7]	JIANG Peng-li, WU Jing, SUN He. Association of cognitive decline, diabetes mellitus and cancer with statins use: gaining insight through the FDA pharmacovigilance database [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1132-1138.
[8]	WANG Pan, XIE Shan-shan, GUO Jian-jun, BU Hai-zhi, CHEN Xi-jing. Research overview in absorption, distribution, metabolism and excretion of dihydropyridine calcium antagonists [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 937-943.
[9]	WANG Zhen-shan, LI Ling, DENG Xiao-lan, LI Hui, YU Min, YAN Jin, CHEN Ben-mei, YANG Guo-ping, OU-YANG Dong-sheng. LC-MS determination of terazosin in human plasma and application [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(5): 530-534.
[10]	ZHANG Hong-xia, WU Yong-jie, GAO Ming-tang. Protective effects of DDPH on myocardial ischemia reperfusion injury in isolated rat hearts [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 160-165.
[11]	WANG Zhan-qing, WANG Jin-ping, XU Jing-feng. Isosorbide dinitrate induces late preconditioning against myocardial infarction in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(12): 1385-1388.
[12]	ZHU Shen-yin, ZHOU Yuan-da, DU Guan-hua. Research progress of xanthine oxidoreductase in biological functions and its inhibitor development [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1081-1086.
[13]	XUE Hao, GAO Min, LIU Guo-shu, WANG Hai. Effect of iptakalim hydrochloride on extracellular matrix of kidney in spontaneously hypertensive rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1122-1128.
[14]	WANG Zhan-qing, YING Xiang-yu, XU Jing-feng. Advances in preclinical studies on combination therapy of myocardial ischemia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 847-850.
[15]	YU Shuang, YU Li-mei, YUAN Mu, YU Hong, WU Qin, SHI Jin-shan. Effect of naftopidil'ramification-BWYJ on benign prostatic hyperplasia in mice and rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 873-877.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments